Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Deloitte
Queensland Health
Accenture
Colorcon

Generated: August 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for LEE011

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for LEE011

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
LEE011   Try a Free Trial Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH)   Try a Free Trial
LEE011   Try a Free Trial Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer Novartis AG (Basel, CH)   Try a Free Trial
LEE011   Try a Free Trial Compounds and compositions as inhibitors of MEK Novartis AG (Basel, CH)   Try a Free Trial
LEE011   Try a Free Trial Androgen receptor mutation Novartis AG (Basel, CH)   Try a Free Trial
LEE011   Try a Free Trial Pharmaceutical combinations Novartis AG (Basel, CH)   Try a Free Trial
LEE011   Try a Free Trial Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof Crystal Pharmatech Co., Ltd. (Suzhou, Jiangsu, CN)   Try a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for LEE011

Drugname Country Document Number Estimated Expiration Related US Patent
LEE011 Australia 2014348657 2033-11-13   Try a Free Trial
LEE011 Australia 2017245411 2033-11-13   Try a Free Trial
LEE011 Canada 2929181 2033-11-13   Try a Free Trial
LEE011 China 105899232 2033-11-13   Try a Free Trial
LEE011 Eurasian Patent Organization 201690987 2033-11-13   Try a Free Trial
LEE011 European Patent Office 3068435 2033-11-13   Try a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Federal Trade Commission
Fuji
Deloitte
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.